Tuesday, February 9, 2016
Quorum Review, an independent institutional review board fully accredited by the Association for the Accreditation of Human Research Protection Programs (AAHRPP), has launched Kinetiq, a software and consulting group. Kinetiq is a division of Quorum, with a focus on providing a broad array of consulting and IT services to the global research community.
Icon, a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, has launched Flex Advantage, a next-generation Interactive Response Technology (IRT) platform that offers enhanced randomization and clinical supply management capabilities and supports the execution of adaptive trials.
The Alliance for Clinical Research Excellence and Safety (ACRES), a global public-interest collaboration building a comprehensive system to transform clinical research, has announced a major second step toward full implementation of a multi-stakeholder shared information technology platform.
Veeva Systems has introduced the Veeva TMF Maturity Model, a complimentary consultative service designed to assess the state of a life sciences organization’s trial master file (TMF) strategy and provide a roadmap for improvement. The Veeva TMF Maturity Model gives practical, step-by-step guidance to help companies transform their TMF from a static archive into a strategic asset that can help increase the efficiency of clinical trials. It is available as a self-service online tool or as a more detailed, in-person evaluation with a seasoned subject matter expert.
Catalent, a global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, has announced a research collaboration with Roche to develop next-generation molecules coupling different therapeutic modalities using Catalent’s proprietary SMARTag technology.
UCL is launching the UCL Technology Fund to invest £50 million ($55 million) in commercializing its research emerging over the next five years. The Fund will be used to support academics whose research has commercial potential, with funding for early stage proof-of-concept, licensing projects and new spinout companies.
The global clinical trial management system market was valued at $844 million in 2013 and is expected to grow at a CAGR of 14% from 2014 to 2019, to reach an estimated value of $1,848.5 million in 2019, according to a new market report published by Persistence Market Research, a U.S.-based full-service market intelligence firm.